Table 4.
ASCQ-Me domaina | 0–3 VOCs in the past 12 months | ≥ 4 VOCs in the past 12 months | Pb | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
N | Mean | SD | Median | IQR | N | Mean | SD | Median | IQR | ||
Emotional impact | 160 | 48.16 | 8.33 | 47.40 | 42.50–54.25 | 143 | 44.80 | 7.23 | 44.90 | 39.90–48.70 | 0.001 |
Social functioning impact | 160 | 49.92 | 9.48 | 48.80 | 43.90–55.80 | 143 | 43.73 | 7.71 | 43.90 | 38.70–48.80 | < 0.001 |
Stiffness impact | 160 | 48.20 | 8.72 | 48.10 | 42.70–52.70 | 143 | 44.67 | 7.52 | 45.40 | 39.90–49.50 | 0.001 |
Sleep impact | 160 | 49.87 | 6.65 | 49.70 | 45.00–55.30 | 143 | 47.42 | 6.19 | 46.70 | 43.20–51.10 | < 0.001 |
Pain impact | 160 | 50.06 | 9.49 | 48.50 | 44.40–58.00 | 143 | 45.41 | 8.89 | 45.70 | 38.30–51.20 | < 0.001 |
ASCQ-Me Adult Sickle Cell Quality of Life Measurement Information System, VOCs vaso-occlusive crises, SD standard deviation, IQR inter-quartile range, HRQoL Health-related quality of life
aHigher ASCQ-Me impact scores indicate better functioning
bAfter Bonferroni correction, all associations remained statistically significant, with P < the Bonferroni correction-adjusted critical value of 0.01